VICTORIA, British Columbia--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a leader in AI-driven biotherapeutic research and technology, is excited to announce ...
Jacob Holm was flipping through proofs from an October 2019 research paper he and colleague Eva Rotenberg—an associate professor in the department of applied mathematics and computer science at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback